Every AI express, investors ask on the investor interaction platform: what is the main business of the company? China is ready to liberalize covid-19 self inspection. The market is huge. Does the company consider extending its business in this regard? The company said that covid-19 testing is mainly carried out by participating companies Xiamen Zhishan biology. We also have business cooperation with Xiamen Zhishan biology in Xiamen. We haven’t seen them do covid-19 testing. Only Xiamen Bosheng biology has covid-19 related business in Xiamen. Xiamen is a positive biology, Xiamen Baotai biology and Xiamen Anbang biology. We have cooperation with these biological companies, Where is the covid-19 business of Zhishan biology? Don’t fool investors?
Dirui Industrial Co.Ltd(300396) ( Dirui Industrial Co.Ltd(300396) . SZ) said on the investor interaction platform on April 23, thank you for your attention! Based on the field of in vitro diagnosis, the company’s products cover seven series: urinalysis, biochemical analysis, blood cell analysis, chemiluminescence immunoassay, gynecological secretion analysis, coagulation analysis and standardized laboratory. Covid-19 antigen detection products of the company are under registration. Zhishan biology is a joint-stock company of the company. Its business mainly focuses on molecular diagnosis technology and integrates the R & D, production and sales of molecular diagnostic reagents and molecular diagnostic instruments. For the business structure and sales related information of Zhishan biology, please refer to its disclosure.
